{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T14:17:18Z","timestamp":1783520238539,"version":"3.55.0"},"reference-count":38,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"unspecified","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs program","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Glob Health"],"accepted":{"date-parts":[[2026,6,20]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>National essential medicines lists (NEMLs) guide medicine selection and procurement and are key tools for promoting equitable access. While countries adapt their lists to national priorities, underlying medical needs are broadly similar across settings; however, factors beyond epidemiological need influence which medicines are included on national lists. We assessed whether countries can be empirically grouped based on their NEML content and examined how these groupings relate to geography, economic status and selected health system characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We assessed NEMLs from 158 WHO Member States and selected non-Member States and territories. Countries were clustered using k-means analysis applied to principal components derived from binary medicine-inclusion data. Cluster profiles were characterised using ORs and compared across WHO region, gross domestic product (GDP) per capita, health expenditure, life expectancy and population size.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Four medicine-based clusters were identified. Cluster 1 (66 countries, 41.8%), largely from the African Region and the Region of the Americas, emphasised medicines for infectious and neglected diseases, vaccines and antisera. Cluster 2 (65 countries, 41.1%) included countries from multiple regions listing a heterogeneous mix of older, off-patent medicines for symptomatic management and selected chronic conditions. Cluster 3 (18 countries, 11.4%), primarily from the European, Eastern Mediterranean and Region of the Americas, prioritised medicines for chronic noncommunicable diseases. Cluster 4 (9 countries, 5.7%), predominantly from the European Region, included newer, higher cost medicines. Cluster membership was significantly associated with WHO region (\u03c7\u00b2, p&lt;0.001), but clusters did not correspond exclusively to any single region or income group, with substantial within-cluster heterogeneity in GDP and health expenditure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Countries can be grouped according to the medicines prioritised on their NEMLs. These clusters reflect patterns in medicine selection and related health system policies that cut across traditional geographic and economic classifications and provide a complementary framework for comparative health system analysis and policy benchmarking.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjgh-2026-024404","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T13:25:11Z","timestamp":1783517111000},"page":"e024404","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Clustering of countries based on national essential medicines lists: cross-sectional study"],"prefix":"10.1136","volume":"11","author":[{"given":"Adelaide","family":"Buadu","sequence":"first","affiliation":[{"name":"MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital, Unity Health Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moizza Zia","family":"Ul Haq","sequence":"additional","affiliation":[{"name":"MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital, Unity Health Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Heredia","sequence":"additional","affiliation":[{"name":"MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital, Unity Health Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Rizvi","sequence":"additional","affiliation":[{"name":"MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital, Unity Health Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aine","family":"Workentin","sequence":"additional","affiliation":[{"name":"MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital, Unity Health Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3327-5580","authenticated-orcid":false,"given":"Nav","family":"Persaud","sequence":"additional","affiliation":[{"name":"MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital, Unity Health Toronto, Toronto, Ontario, Canada"},{"name":"Department of Family and Community Medicine, St. Michael\u2019s Hospital, Unity Health Toronto, Toronto, Ontario, Canada"},{"name":"Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"2026070806250823000_11.7.e024404.1","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.18.222448"},{"key":"2026070806250823000_11.7.e024404.2","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-053349","article-title":"Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO","volume":"12","author":"Piggott","year":"2022","journal-title":"BMJ Open"},{"key":"2026070806250823000_11.7.e024404.3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1000353","article-title":"A dynamic network approach for the study of human phenotypes","volume":"5","author":"Hidalgo","year":"2009","journal-title":"PLoS Comput Biol"},{"key":"2026070806250823000_11.7.e024404.4","unstructured":"World Health Organization,International Bank for Reconstruction and Development\/ The World Bank . Tracking universal health coverage: 2021 global monitoring report. 2021. Available: https:\/\/www.who.int\/publications\/i\/item\/9789240040618"},{"key":"2026070806250823000_11.7.e024404.5","unstructured":"World Health Organization . Global status report on noncommunicable diseases 2014. Geneva World Health Organization; 2014. Available: https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/83f2cb9d-8c31-482a-baa8-83b6005ce5e5\/content"},{"key":"2026070806250823000_11.7.e024404.6","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(20)30925-9"},{"key":"2026070806250823000_11.7.e024404.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60393-0"},{"key":"2026070806250823000_11.7.e024404.8","unstructured":"World Health Organization . World health organization model list of essential medicines \u2013 22nd list (2021). Geneva World Health Organization; 2021. Available: https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/285bb318-3177-4ed6-8fc9-5d1106220fa4\/content"},{"key":"2026070806250823000_11.7.e024404.9","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0140-6736(03)13375-2","article-title":"25 years of the WHO essential medicines lists: progress and challenges","volume":"361","author":"Laing","year":"2003","journal-title":"The Lancet"},{"key":"2026070806250823000_11.7.e024404.10","unstructured":"Organization WH . 1035. The selection and use of essential medicines [who technical report]. Geneva WHO; 2021."},{"key":"2026070806250823000_11.7.e024404.11","unstructured":"Organization WH . The selection and use of essential medicines: report of the who expert committee on selection and use of essential medicines, 2021 (including the 22nd who model list of essential medicines and the 8th who model list of essential medicines for children). Geneva World Health Organization; 2021.1035."},{"key":"2026070806250823000_11.7.e024404.12","unstructured":"Bigdeli M , Peters DH , Wagner AK . Medicines in health systems: advancing access, affordability and appropriate use. Geneva World Health Organization; 2014. Available: https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/bef809eb-82f5-4478-a5cd-54df8fb2c417\/content"},{"key":"2026070806250823000_11.7.e024404.13","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0140-6736(16)31599-9","article-title":"Essential medicines for universal health coverage","volume":"389","author":"Wirtz","year":"2017","journal-title":"The Lancet"},{"key":"2026070806250823000_11.7.e024404.14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087576","article-title":"Essential medicines are more available than other medicines around the globe","volume":"9","author":"Bazargani","year":"2014","journal-title":"PLoS ONE"},{"key":"2026070806250823000_11.7.e024404.15","unstructured":"Holloway K , Dijk L . The world medicines situation 2011 rational use of medicines. Geneva World Health Organization; 2011."},{"key":"2026070806250823000_11.7.e024404.16","unstructured":"WHO Council on the Economics of Health for All . Health for all: transforming economies to deliver what matters: final report of the who council on the economics of health for all. Geneva World Health Organization; 2023."},{"key":"2026070806250823000_11.7.e024404.17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001724","article-title":"WHO essential medicines policies and use in developing and transitional countries: an analysis of reported policy implementation and medicines use surveys","volume":"11","author":"Holloway","year":"2014","journal-title":"PLoS Med"},{"key":"2026070806250823000_11.7.e024404.18","unstructured":"World Health Organization . Anatomical Therapeutical Chemical (ATC) classification, 2024. Available: https:\/\/atcddd.fhi.no\/atc_ddd_index\/"},{"key":"2026070806250823000_11.7.e024404.19","unstructured":"Persson M , Wilking N , Kalin M , et al . Medicines information extraction and validation using automated and manual approaches. BMC Med Inf Decis Mak 2020;20. doi:10.1186\/s12911-020-01196-6"},{"key":"2026070806250823000_11.7.e024404.20","unstructured":"Central Intelligence Agency . Country comparisons - the world factbook. 2024 Available: https:\/\/www.cia.gov\/the-world-factbook\/field\/population\/country-comparison\/"},{"key":"2026070806250823000_11.7.e024404.21","unstructured":"United Nations . Revision of world population prospects. 2022. Available: https:\/\/www.un.org\/development\/desa\/pd\/data-landing-page"},{"key":"2026070806250823000_11.7.e024404.22","unstructured":"World Health Organization . Global health observatory (gho) data - current health expenditure (che) per capita in us$. 2023. Available: https:\/\/www.who.int\/data\/gho\/data\/indicators\/indicator-details\/GHO\/current-health-expenditure-(che)-per-capita-in-us-dollar"},{"key":"2026070806250823000_11.7.e024404.23","unstructured":"Global burden of disease collaborative network . Global burden of disease study 2019 (gbd 2019) healthcare access and quality index 1990-2019. Institute for Health Metrics and Evaluation (IHME); 2022. Available: https:\/\/ghdx.healthdata.org\/record\/ihme-data\/gbd-2019-healthcare-access-and-quality-1990-2019"},{"key":"2026070806250823000_11.7.e024404.24","article-title":"Principal component analysis: a review and recent developments","volume":"374","author":"Jolliffe","year":"2016","journal-title":"Philos Trans A Math Phys Eng Sci"},{"key":"2026070806250823000_11.7.e024404.25","doi-asserted-by":"crossref","unstructured":"Jackson JE . A user\u2019s guide to principal components. New York: Wiley, 1991.","DOI":"10.1002\/0471725331"},{"key":"2026070806250823000_11.7.e024404.26","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/wics.101","article-title":"Principal component analysis","volume":"2","author":"Abdi","year":"2010","journal-title":"WIREs Computational Stats"},{"key":"2026070806250823000_11.7.e024404.27","unstructured":"Kolenikov S , Angeles G , Meas Eval . The use of discrete data in pca: theory, simulations, and applications to socioeconomic indices. 2004."},{"key":"2026070806250823000_11.7.e024404.28","unstructured":"Costello AB , Osborne J . Best practices in exploratory factor analysis: four recommendations for getting the most from your analysis. 2005. doi:10.7275\/JYJ1-4868"},{"key":"2026070806250823000_11.7.e024404.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.patrec.2009.09.011"},{"key":"2026070806250823000_11.7.e024404.30","doi-asserted-by":"crossref","unstructured":"Everitt BS , Landau S , Leese M , et al . Cluster analysis 5th ed. Chichester: Wiley, 2011.","DOI":"10.1002\/9780470977811"},{"key":"2026070806250823000_11.7.e024404.31","unstructured":"Kaufman L , Rousseeuw PJ . Finding groups in data: An introduction to cluster analysis. Hoboken: Wiley, 2005."},{"key":"2026070806250823000_11.7.e024404.32","doi-asserted-by":"crossref","unstructured":"Kirk RE . Experimental design: Procedures for the behavioral sciences 4th ed. Thousand Oaks: Sage Publications, 2013.","DOI":"10.4135\/9781483384733"},{"key":"2026070806250823000_11.7.e024404.33","doi-asserted-by":"publisher","DOI":"10.2307\/3001913"},{"key":"2026070806250823000_11.7.e024404.34","unstructured":"Rothman KJ , Lash TL , VanderWeele TJ , et al . Modern epidemiology Fourth edition. Philadelphia: Wolters Kluwer \/ Lippincott Williams & Wilkins, 2021:1."},{"key":"2026070806250823000_11.7.e024404.35","unstructured":"Szumilas M . Explaining Odds Ratios. J Can Acad Child Adolesc Psychiatry 2010."},{"key":"2026070806250823000_11.7.e024404.36","unstructured":"Han J , Kamber M , Pei J . Data mining: Concepts and techniques. 3rd edn. Amsterdam Boston: Elsevier\/Morgan Kaufmann, 2012."},{"key":"2026070806250823000_11.7.e024404.37","unstructured":"StataCorp . Stata statistical software: release 19. College Station, TX StataCorp LLC; 2024."},{"key":"2026070806250823000_11.7.e024404.38","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.healthpol.2019.12.010","article-title":"Variation in the prescription drugs covered by health systems across high-income countries: A review of and recommendations for the academic literature","volume":"124","author":"Morgan","year":"2020","journal-title":"Health Policy"}],"container-title":["BMJ Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgh-2026-024404","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T13:25:17Z","timestamp":1783517117000},"score":1,"resource":{"primary":{"URL":"https:\/\/gh.bmj.com\/lookup\/doi\/10.1136\/bmjgh-2026-024404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":38,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,8]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/bmjgh-2026-024404"],"URL":"https:\/\/doi.org\/10.1136\/bmjgh-2026-024404","relation":{},"ISSN":["2059-7908"],"issn-type":[{"value":"2059-7908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}